Virginia Retirement Systems Et Al Alx Oncology Holdings Inc Transaction History

Virginia Retirement Systems Et Al

  • $10.1 Billion
  • Q3 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Jul 11, 2023
SELL
$4.52 - $11.71 $5,875 - $15,223
-1,300 Reduced 8.9%
13,300 $60,000
Q4 2022

May 17, 2023
SELL
$9.51 - $12.95 $6,657 - $9,065
-700 Reduced 4.58%
14,600 $165 Million
Q3 2022

May 16, 2023
BUY
$8.23 - $15.14 $125,919 - $231,642
15,300 New
15,300 $146 Million

Others Institutions Holding ALXO

# of Institutions
100
Shares Held
39.8M
Call Options Held
134K
Put Options Held
17.4K
View Full List

About ALX ONCOLOGY HOLDINGS INC

ALXO Quotes by TradingView
  • Ticker ALXO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,747,100
  • Market Cap $48.9M
  • Description
  • ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...
More about ALXO
Track This Portfolio

Track Virginia Retirement Systems Et Al Portfolio

Follow Virginia Retirement Systems Et Al and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email